Press Release: Amlan International Names Dr. Edwin Chow as Technical Service Director to Drive Innovation Across APAC

Dow Jones
昨天

CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Amlan International, the animal health business of Oil-Dri Corporation of America $(ODC)$, is pleased to announce the appointment of Edwin Pei Yong Chow, Ph.D., as Technical Service Director, Asia-Pacific $(APAC)$. In this role, Dr. Chow will report to Dr. Michael Hua, Regional Director, APAC, and will be responsible for leading Amlan's technical service tactics across the region, supporting business growth through customer engagement, technical innovation, and training.

With more than 15 years of experience in animal health, feed additives, and nutrition, Dr. Chow brings a wealth of expertise spanning research, product development, technical service, and commercialization. He has held senior scientific and management positions at Berg+Schmidt, Adisseo, and Kemin Industries, where he successfully led regional and global teams focused on developing innovative nutritional and functional solutions for livestock and aquaculture species.

Throughout his career, Dr. Chow has demonstrated a proven ability to translate scientific research into practical applications that deliver measurable performance and profitability for producers. His accomplishments include launching new aquaculture programs across Asia, establishing regional customer testing laboratories, and driving product innovation through collaborative partnerships with universities, government agencies, and industry leaders.

"Dr. Chow brings a unique blend of technical expertise, strategic leadership, and customer-focused insight that will be instrumental in advancing Amlan's mission to improve animal health and productivity naturally," said Dr. Michael Hua, Regional Director, APAC. "His deep knowledge of both feed and nutrition positions us to deliver even greater value to our customers across the diverse markets in Asia-Pacific."

Dr. Chow holds a Ph.D. in Chemistry from the National University of Singapore, where he also serves as an Adjunct Assistant Professor in the Department of Food Science and Technology. His academic and professional achievements are supported by a strong portfolio of published research, patents, and industry contributions that bridgeanimal nutrition, food technology, and applied materials science.

"Joining Amlan is an incredible opportunity to support the future of animal health," said Dr. Chow. "I am passionate about leveraging science and innovation to deliver mineral-based solutions that not only enhance animal performance but also support the long-term success of animal protein producers. Asia-Pacific is a dynamic region with tremendous potential, and I look forward to building strong partnerships with our distributors and customers that drive growth and create lasting impact."

Amlan International is the animal health business of Oil-Dri Corporation of America, a leading global manufacturer and marketer of sorbent minerals. Oil-Dri leverages over 80 years of expertise in mineral science to selectively mine and process its unique mineral for consumer and business-to-business markets. Oil-Dri Corporation of America doing business as "Amlan International" is a publicly traded stock on the New York Stock Exchange (NYSE: ODC). Amlan International sells feed additives across the world. Product availability may vary by country; associated claims do not constitute medical claims and may differ based on government requirements. For more information on Amlan International, please visit www.amlan.com.

Contact:

Reagan Culbertson, Vice President of Strategic Marketing, B2B

Reagan.culbertson@amlan.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f473b080-667c-4016-ae88-f02be8849617

(END) Dow Jones Newswires

December 01, 2025 16:00 ET (21:00 GMT)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10